Patient Intake At the 'MOvement and REhabilitation (MO.RE.) (BACKMORE2024)

Patient Intake At the 'MOvement and REhabilitation (MO.RE.)' Clinic: a Retrospective Observational Study on the Appropriateness of Access and the Needs Expressed by Patients. (BACKMORE2024)

In recent years, there has been an exponential increase in studies regarding the benefits of physical activity in oncology, with significant results on improving both physical and psychological outcomes. When appropriately dosed, physical activity can help individuals with a history of cancer to cope with pain and Cancer-Related Fatigue, and improve their quality of life, both during and after cancer treatments.

Given the incidence and prevalence of cancer, along with the increase in survival due to advancements in cancer care, it is becoming increasingly important to promote an active lifestyle.

For this reason, in August 2022, the MOvement and REhabilitation (MO.RE.) clinic was opened by the S.C. of MFR, dedicated to individuals with a history of cancer at any stage of treatment, with the aim of offering consultations with an experienced physiotherapist to personalize a physical activity program that can help regain a good quality of life, return to daily activities, and prevent the onset of other diseases and recurrences.

The clinic also provides therapeutic education activities, following WHO guidelines, on proper lifestyle for wellness and secondary prevention.

The aim of our study is to retrospectively analyze the patients who requested a consultation at the MO.RE. clinic between August 2022 and June 2024, in order to describe and evaluate the appropriateness of access to the clinic, the expressed needs, and some clinical and rehabilitative data."

Study Overview

• Status: Completed
• Conditions: Oncologic Complications

• Study Type: Observational
• Enrollment (Actual): 95

Contacts and Locations

Study Locations

• Italy
  • Reggio Emilia, Italy, 42123
    • AUSL-IRCCS of Reggio EmiliaOperational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia, Reggio Emilia, Emilia Romagna 42123

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients with a history of malignant tumor diagnosis, managed by the Oncology and Hematology Units of the USL-IRCCS of Reggio Emilia, who requested a consultation at the MO.RE. clinic between August 2022 and June 2024

Description

Inclusion Criteria:

• Diagnosis of malignant tumor
• Access to the MO.RE. clinic for recommendations on exercise/physical activity
• Age over 18 years

Exclusion Criteria:

• Language barrier
• Conditions that prevent the individual from performing physical activity independently

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Patients who requested a consultation at the MO.RE. clinic between August 2022 and June 2024; Patients with a history of malignant tumor diagnosis, managed by the Oncology and Hematology Units that need a MO.RE. clinic consultation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of cancer patients who accessed the MO.RE. service, matching appropriateness criteria	The referral of the patient is considered appropriate, if the patient corresponds to these criteria: cancer patient needing information about a personalized physical activity program; patient with a good performance status evaluated according to ECOG performance status scale (score 0 or 1); absence of bone metastases.	2 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Sample description by socio-demographic data	To describe the sample, data will be collected at the first access at MO.RE. service, concerning: age (measured in years); gender (M/F); education level (number of years attending school); occupation (descriptive); Municipality of residence (distance from hospital).	2 years
Sample description by clinical data	To describe the sample, data will be collected at the first access at MO.RE. service, concerning: Performance status at the first access to MO.RE. service; Location of primary tumor; Ongoing anticancer therapy; surgery (type of intervention and time elapsed between surgery and access to the MO.RE. service); Complications, if any; Presence of bone metastases; Description of any ongoing or completed rehabilitation program; Amount of physical activity pre- and post-cancer diagnosis; Signs and symptoms related to cancer or anticancer therapies; patients specific needs; patient referral (how did patients access MO.RE. service? by oncologist referral, by other patients suggestion, information by social media, other)	2 years
Number of cancer patients who needed counselling on physical activity and self-managed exercise after MO.RE. access	At the end of the evaluation at MO.RE. service, a number of empowered cancer patients are able to self-manage physical activity in their life, after receiveing specific information about type, intensity, timing and frequency of appropriate exercise.	2 years
Number of cancer patients who needed counselling on physical activity and self-managed exercise after MO.RE. access	At the end of the evaluation at MO.RE. service, a number of cancer patients need a supervision by a physiotherapist, to become able to self-manage physical activity in their life. These patients receive a supervised rehabilitation program, to learn specific type, intensity, timing and frequency of appropriate exercise matching their condition.	2 years
Number of cancer patients who needed a physiatrist evaluation before exercise	At the end of the evaluation at MO.RE. service, a number of cancer patients need a physiatrist consultation, to avoid adverse events correlated with bone metastases or because they need a specific medical evaluation before exercise.	2 years

Collaborators and Investigators

• Sponsor: Azienda Unita Sanitaria Locale Reggio Emilia
• Investigators: Principal Investigator: Stefania Fugazzaro, MD, AUSL-IRCCS of Reggio Emilia

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2022
• Primary Completion (Actual): June 30, 2024
• Study Completion (Actual): June 30, 2024

Study Registration Dates

• First Submitted: February 4, 2025
• First Submitted That Met QC Criteria: February 27, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 27, 2025
• Last Verified: February 1, 2025

More Information

Terms related to this study

• Keywords: Physical Activity; Physical Exercise; Onc-hematological patients
• Other Study ID Numbers: 299/2024/OSS/AUSLRE

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No